ImmunityBio, Inc. (IBRX)
8.70
+0.09
(+1.05%)
USD |
NASDAQ |
Feb 20, 16:00
8.70
0.00 (0.00%)
After-Hours: 20:00
ImmunityBio Shareholders Equity (Quarterly) : -524.32M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novavax, Inc. | -156.67M |
| Krystal Biotech, Inc. | 1.220B |
| Rapt Therapeutics, Inc. | 151.98M |
| Moderna, Inc. | 8.65B |
| Corcept Therapeutics, Inc. | 631.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 518.99M |
| Total Liabilities (Quarterly) | 1.042B |
| Debt to Equity Ratio | -1.643 |
| Current Ratio | 5.767 |
| Net Debt Paydown Yield | 1.14% |